Literature DB >> 34567944

Interdigitating dendritic cell sarcoma of pleura, diagnostic challenges of a rare disease.

Nitin Gupta1, Shashi Dhawan2, Ritu Verma1, Ethel Shangne Belho1, Rinky Agarwal3.   

Abstract

Interdigitating dendritic cell sarcoma (IDCS) is an extremely rare subtype of dendritic cell tumour. The solitary lymph node disease is most commonly seen, but may occasionally present extranodally in skin, intestines, soft tissue, liver or spleen. Here we present a case of IDCS in pleura in 53-year-old man, who presented with loss of appetite and chest pain. The initial biopsy was inconclusive. The patient was started on anti-tubercular treatment considering the higher prevalence of the disease in this part of the world. However, the symptoms worsened after 2 months and repeat PET-CT scan revealed extensive FDG avid lesions in the multiple sites in the body. Repeat PET guided biopsy confirmed this rare IDCS neoplasm. Diagnostic challenges of this rare tumour are discussed. © The Japan Society of Clinical Oncology 2021.

Entities:  

Keywords:  FDG PET/CT; Histopathology; Interdigitating dendritic cell sarcoma; Pleura

Year:  2021        PMID: 34567944      PMCID: PMC8421505          DOI: 10.1007/s13691-021-00498-8

Source DB:  PubMed          Journal:  Int Cancer Conf J        ISSN: 2192-3183


  13 in total

1.  Clonal cytogenetic abnormalities and BCL2 rearrangement in interdigitating dendritic cell sarcoma.

Authors:  Hassan Nayer; Kathleen M Murphy; Anita L Hawkins; Patricia P Long; Maura Gillison; Michael Borowitz; Constance A Griffin
Journal:  Leuk Lymphoma       Date:  2006-12

2.  Extranodal interdigitating dendritic cell sarcoma presenting in the pleura: a case report.

Authors:  Hye-Suk Han; Ok-Jun Lee; Sung-nam Lim; Jin Young An; Ki Man Lee; Kang Hyeon Choe; Ki Hyeong Lee; Seung Taik Kim
Journal:  J Korean Med Sci       Date:  2011-01-24       Impact factor: 2.153

3.  Multifocal Interdigitating Dendritic Cell Sarcoma Demonstrated on FDG PET/CT Imaging.

Authors:  Xia Bai; Xiangcheng Wang; Xuemei Wang
Journal:  Clin Nucl Med       Date:  2020-09       Impact factor: 7.794

4.  Lymph node interdigitating cell sarcoma. A case report.

Authors:  M Yamakawa; M Matsuda; Y Imai; S Arai; K Harada; T Sato
Journal:  Am J Clin Pathol       Date:  1992-01       Impact factor: 2.493

5.  Tumours of histiocytes and accessory dendritic cells: an immunohistochemical approach to classification from the International Lymphoma Study Group based on 61 cases.

Authors:  S A Pileri; T M Grogan; N L Harris; P Banks; E Campo; J K C Chan; R D Favera; G Delsol; C De Wolf-Peeters; B Falini; R D Gascoyne; P Gaulard; K C Gatter; P G Isaacson; E S Jaffe; P Kluin; D M Knowles; D Y Mason; S Mori; H-K Müller-Hermelink; M A Piris; E Ralfkiaer; H Stein; I-J Su; R A Warnke; L M Weiss
Journal:  Histopathology       Date:  2002-07       Impact factor: 5.087

Review 6.  Follicular dendritic cell sarcoma and interdigitating reticulum cell sarcoma: a review.

Authors:  R Fonseca; M Yamakawa; S Nakamura; P van Heerde; M Miettinen; T W Shek; O Myhre Jensen; M C Rousselet; A Tefferi
Journal:  Am J Hematol       Date:  1998-10       Impact factor: 10.047

7.  A malignant tumor arising from interdigitating cells; light microscopical, ultrastructural, immuno-and enzyme-histochemical characteristics.

Authors:  C A Feltkamp; P van Heerde; T M Feltkamp-Vroom; J Koudstaal
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1981

Review 8.  Dendritic cell sarcoma: a pooled analysis including 462 cases with presentation of our case series.

Authors:  Caner Saygin; Didem Uzunaslan; Mustafa Ozguroglu; Mustafa Senocak; Nukhet Tuzuner
Journal:  Crit Rev Oncol Hematol       Date:  2013-06-05       Impact factor: 6.312

9.  Interdigitating dendritic cell sarcoma: a rare malignancy responsive to ABVD chemotherapy.

Authors:  M J Olnes; T Nicol; M Duncan; M Bohlman; R Erlich
Journal:  Leuk Lymphoma       Date:  2002-04

Review 10.  Interdigitating dendritic cell sarcoma located in the groin: a case report and literature review.

Authors:  Hong-Tao Wang; Hong-Yang Xu; Rong Zhang; Zhuo-Gang Liu; Guo-Jun Zhang
Journal:  J Int Med Res       Date:  2018-09-17       Impact factor: 1.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.